Benign neoplasm: Lacrimal gland and duct

CD2_BENIGN_LACRIMAL

choriocarcinoma: An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D31.5& Hospital discharge: ICD-9 — 2247 Cause of death: ICD-10 — D31.5& Cause of death: ICD-9 — 2247 2 out of 7 registries used, show all original rules.	41
4. Check minimum number of events None	41
5. Include endpoints None	41
6. Filter based on genotype QC (FinnGen only)	41

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D31
Name in latin: Neoplasma benignum glandulae lacrimalis

NAME	CD2_BENIGN_LACRIMAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D315
HD_ICD_9	2247
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D315
COD_ICD_9	2247
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Lacrimal gland and duct based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Lacrimal gland and duct

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	236	155	80
Only index persons	223	151	72
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.01	0.00
Median age at first event (years)
Whole population	57.98	56.98	59.90
Only index persons	57.40	56.94	58.37

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	41	31	10
Unadjusted period prevalence (%)	0.01	0.01	0.00
Median age at first event (years)	63.06	61.60	67.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

5.65

5.23

1.3

—

(40768795) Lymph node Pathology biopsy report

9.76

3.38

1.2

1.1

—

(42870588) Differential panel, method unspecified - Blood

112

3.08

3.4

5.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4.96

2.85

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

6.92

2.44

1.4

1.5

12.2

11.0

mg/l

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2.67

2.27

2.2

2.9

353.2

324.8

umol/l

1.04

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

4.58

1.88

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.48

1.81

1.3

11.3

42.8

iu/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.64

1.75

2.4

2.5

1.2

4.2

e6/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.91

1.66

1.8

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.91

1.59

2.7

2.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

283

2.61

1.51

5.5

7.4

68.1

75.9

u/l

1.40

263

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3.41

1.48

1.4

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.20

1.40

3.0

3.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.20

1.40

2.4

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.27

1.32

2.5

2.4

0.4

1.1

e6/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

302

2.57

1.24

13.0

14.6

39.7

39.8

0.02

221

(3018010) Neutrophils/100 leukocytes in Blood

162

1.96

1.23

4.9

5.9

55.8

56.1

0.04

154

(3018095) Leukocytes [#/volume] in Urine

126

1.95

1.21

2.3

3.5

5.7

73.6

e6/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.70

1.18

1.0

1.7

—

(3013512) EKG study

110

1.93

1.15

4.2

4.5

—

(3022313) Gas panel - Capillary blood

2.57

1.12

3.6

2.1

—

(40768804) Tissue Pathology biopsy report

147

1.88

1.12

2.1

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

237

1.99

1.09

4.8

4.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.02

0.0

1.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1.84

0.96

2.5

2.9

0.1

0.4

e6/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

145

1.74

0.90

2.3

2.1

100.7

96.0

pmol/l

—

(3021589) Normoblasts [#/volume] in Blood

146

1.72

0.87

8.3

11.3

0.0

e9/l

0.50

124

(3002582) Erythrocytes [#/volume] in Urine

110

1.75

0.85

2.3

3.1

16.5

625.3

e6/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

320

2.02

0.78

14.6

15.3

75.3

79.4

ml/min/173m2

0.54

258

(3015736) pH of Urine

131

1.67

0.77

2.4

3.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

169

1.65

0.77

5.3

6.1

28.3

28.7

0.06

158

(3006504) Eosinophils/100 leukocytes in Blood

160

1.64

0.75

5.2

6.1

4.6

2.5

1.95

151

(3019069) Monocytes/100 leukocytes in Blood

162

1.61

0.70

5.4

6.2

8.4

8.7

0.18

153

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.71

0.69

1.0

1.5

—

(3000492) Spirometry study

1.82

0.66

1.4

1.6

—

(3013115) Eosinophils [#/volume] in Blood

174

1.57

0.65

5.1

7.0

0.2

e9/l

0.71

159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

325

1.88

0.65

6.0

5.1

1.9

mu/l

0.16

295

(3013650) Neutrophils [#/volume] in Blood by Automated count

204

1.58

0.64

6.3

10.3

4.3

3.9

e9/l

0.29

181

(3015377) Calcium [Moles/volume] in Serum or Plasma

127

1.58

0.64

2.5

3.2

2.3

2.4

mmol/l

—

113

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

195

1.56

0.62

1.8

2.6

—

(3022096) Basophils/100 leukocytes in Blood

157

1.53

0.60

5.5

6.1

0.8

0.6

1.29

147

(3007853) Bacteria identified in Skin by Aerobe culture

1.78

0.60

1.2

1.3

—

(3019225) pH of Specimen

1.78

0.60

4.5

5.1

—

(3000494) Fungus identified in Specimen by Culture

1.73

0.58

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1.58

0.57

3.3

3.5

24.1

51.1

mg/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.63

0.56

1.0

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

103

1.55

0.55

5.0

4.2

7.1

7.6

mg/mmol

—

(36304419) Bacteria [Presence] in Urine

1.56

0.54

2.5

2.9

—

(3006315) Basophils [#/volume] in Blood

170

1.48

0.53

5.2

6.4

0.0

e9/l

0.31

154

(3001604) Monocytes [#/volume] in Blood

171

1.47

0.50

5.2

6.2

0.5

0.6

e9/l

0.76

154

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.55

0.50

1.0

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.70

0.45

1.6

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

136

1.43

0.43

3.7

4.0

—

(3002256) Pathology report gross observation

1.58

0.43

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3000991) Gas panel - Venous blood

0.00

0.42

0.0

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.49

0.41

2.0

5.0

—

(3044889) 12 lead EKG panel

232

0.73

0.37

4.3

3.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.46

0.37

3.8

8.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.46

0.36

1.9

2.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1.42

0.36

1.2

29.6

—

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

122

1.36

0.33

2.8

3.0

—

(3003694) ABO and Rh group [Type] in Blood

1.38

0.30

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

337

0.77

0.28

6.8

5.8

38.5

40.6

mmol/mol

0.64

312

(3023368) Bacteria identified in Blood by Culture

1.34

0.26

3.6

3.9

—

(3022145) Colonoscopy Study observation

1.32

0.24

1.2

1.1

—

(40758558) Short blood count panel - Blood

1.30

0.23

4.9

7.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3012501) Base excess in Blood by calculation

0.00

0.21

0.0

4.1

—

2.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

4.1

—

5.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

4.1

—

8.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.21

0.0

2.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3047181) Lactate [Moles/volume] in Blood

0.00

0.21

0.0

8.1

—

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.21

0.0

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.23

0.21

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.21

0.20

1.7

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

4.1

—

24.5

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.20

0.0

4.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

0.00

0.20

0.0

7.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

110

1.27

0.20

2.5

3.9

689.9

1245.5

ng/l

—

(3031040) Bacteria [#/volume] in Urine by Automated count

229

1.23

0.19

5.1

4.5

—

1320.0

—

(3044640) Blood type and Crossmatch panel - Blood

105

1.20

0.13

1.8

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

105

1.20

0.13

4.5

3.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

157

1.14

0.09

3.2

4.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

320

1.16

0.07

4.2

4.1

1.4

1.3

mmol/l

0.53

288

(1761868) Lipid panel - Serum or Plasma

111

0.87

0.07

2.4

2.9

—

(3026008) Bacteria identified in Urine by Culture

116

1.05

0.00

3.9

3.1

—

(3032080) INR in Blood by Coagulation assay

142

0.98

0.00

2.2

8.6

1.0

1.2

inr

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.88

0.00

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

3.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.92

0.00

2.7

6.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

11.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.0

—

52.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

3.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.6

—

(40768797) Stomach Pathology biopsy report

0.96

0.00

1.0

1.2

—

(44790047)

0.00

0.0

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

11.7

—

(44790048)

0.00

0.0

1.2

—

(4281824)

0.00

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(44806118)

0.00

0.0

1.2

—

(4146454)

0.00

0.0

3.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.2

—

176.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

332

1.14

0.00

4.9

4.7

1.5

mmol/l

0.18

301

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

327.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

3.2

—

92.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

342

1.16

0.00

5.3

2.8

2.7

mmol/l

0.23

308

(3018572) Chloride [Moles/volume] in Blood

0.00

0.0

6.6

—

104.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

2.2

—

31.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

3.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.00

0.0

4.8

—

25.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

0.89

0.00

2.0

3.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

3.5

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.3

—

57.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

6.6

—

197.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

336

1.07

0.00

5.4

4.7

5.7

5.9

mmol/l

0.61

307

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(44790049)

0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

3.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

4.7

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

18.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.0

1.2

—

(3039000) Anion gap in Blood

0.00

0.0

6.6

—

10.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LACRIMAL and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LACRIMAL.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LACRIMAL – Benign neoplasm: Lacrimal gland and duct

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Lacrimal gland and duct

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints